# Dystonia: Classification, Genetics, and Treatment

## Overview

Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions causing abnormal, often repetitive movements and postures. It is the third most common movement disorder after tremor and parkinsonism. Dystonia can be the sole manifestation (isolated dystonia) or combined with other movement disorders such as parkinsonism or myoclonus. Classification follows two axes: clinical characteristics and etiology.

## Classification

### Axis I: Clinical Characteristics

Age of onset is divided into infancy (under 2 years), childhood (3-12), adolescence (13-20), early adulthood (21-40), and late adulthood (over 40). Body distribution ranges from focal (a single body region, such as cervical dystonia, blepharospasm, writer's cramp, or laryngeal dystonia) through segmental (two or more contiguous regions), multifocal (two or more non-contiguous regions), generalized (trunk plus at least two other regions), to hemidystonia (one half of the body, usually indicating a secondary structural lesion). Temporal patterns include static versus progressive, and persistent, action-specific, diurnal, or paroxysmal. Associated features determine whether the dystonia is isolated or combined with parkinsonism or myoclonus.

### Axis II: Etiology

Inherited dystonia has an identified monogenic cause. Acquired dystonia results from brain injury, drugs, toxins, or other identifiable causes. Idiopathic dystonia has no identified cause and may be sporadic or familial.

<image>Classification schema for dystonia showing the two-axis system with clinical characteristics and etiological categories</image>

## Focal Dystonias

### Cervical Dystonia (Spasmodic Torticollis)

Cervical dystonia is the most common focal dystonia in adults. It produces involuntary head postures including torticollis (rotation), laterocollis (lateral tilt), anterocollis (flexion), retrocollis (extension), or combinations of these. Dystonic tremor, which is jerky and irregular, frequently accompanies the abnormal posture. The sensory trick (geste antagoniste), where light touch to the chin or face reduces the dystonia, is a characteristic and diagnostically useful feature. Pain is common, affecting 60-75% of patients.

### Blepharospasm

Blepharospasm involves involuntary bilateral eyelid closure from orbicularis oculi spasm. It can cause functional blindness despite normal visual acuity and is associated with increased blink rate and photosensitivity. It must be distinguished from hemifacial spasm, which is unilateral, irregular, and involves the lower face.

### Laryngeal Dystonia (Spasmodic Dysphonia)

The adductor type, which is the most common form, produces a strained, strangled voice quality. The abductor type creates a breathy, whispery voice. It is characteristically task-specific, often worse with conversational speech but better with singing or laughing.

### Writer's Cramp

Writer's cramp is a task-specific dystonia of the hand and forearm occurring during writing. It may spread to other manual tasks (termed simple when restricted to writing, dystonic when generalized to other hand activities) and is the most common occupational dystonia.

### Oromandibular Dystonia

Oromandibular dystonia produces involuntary jaw movements including jaw opening, closing, or lateral deviation. When combined with blepharospasm, it constitutes Meige syndrome.

## Genetic Dystonias

| Genetic Dystonia | Gene | Inheritance | Onset | Key Features |
|---|---|---|---|---|
| DYT-TOR1A (DYT1) | TOR1A | AD (30% penetrance) | Childhood (mean 12) | Limb-onset generalizing; Ashkenazi Jewish |
| DYT-THAP1 (DYT6) | THAP1 | AD | Variable | Cranial-cervical; prominent laryngeal involvement |
| DYT/PARK-GCH1 (Segawa) | GCH1 | AD | Childhood | Diurnal fluctuation; dramatic levodopa response |
| DYT-SGCE (myoclonus-dystonia) | SGCE | AD (maternal imprinting) | Childhood-adolescent | Upper body myoclonus + dystonia; alcohol-responsive |
| DYT-KMT2B | KMT2B | AD | Childhood | Generalized dystonia + intellectual disability |
| Wilson disease | ATP7B | AR | <50 years | Dystonia + parkinsonism + liver disease; treatable |

### DYT-TOR1A (DYT1)

DYT-TOR1A is the most common genetic cause of early-onset generalized dystonia. It follows autosomal dominant inheritance with approximately 30% penetrance. The mutation is a GAG deletion in the TOR1A gene on chromosome 9q34. Onset is typically in childhood (mean age 12), usually beginning in a limb and subsequently generalizing. It is more common in the Ashkenazi Jewish population. Brain imaging is normal, and DaTscan is normal, distinguishing it from dopa-responsive dystonia.

### DYT-THAP1 (DYT6)

DYT-THAP1 follows autosomal dominant inheritance with variable penetrance. It often starts in the cranial-cervical region or upper limb and may present with a mixed phenotype with prominent laryngeal involvement.

### DYT/PARK-GCH1 (Dopa-Responsive Dystonia / Segawa Disease)

This condition results from autosomal dominant mutations in GCH1 (GTP cyclohydrolase 1). It presents with childhood-onset lower limb dystonia featuring characteristic diurnal fluctuation, with symptoms worsening in the evening and improving after sleep. The hallmark is a dramatic and sustained response to low-dose levodopa. This diagnosis must be considered in any child with dystonia, and a levodopa trial is mandatory. It can also present as parkinsonism in adults.

### DYT-SGCE (Myoclonus-Dystonia)

Myoclonus-dystonia follows autosomal dominant inheritance with maternal imprinting (disease is caused by paternal inheritance). It features a combination of predominantly upper-body myoclonus (lightning-like jerks) and dystonia. It is alcohol-responsive, and psychiatric comorbidity including anxiety, OCD, and depression is common. There is an excellent response to GPi DBS.

### Other Genetic Forms

DYT-KMT2B causes childhood-onset generalized dystonia with intellectual disability. DYT-ANO3 produces adult-onset craniocervical dystonia with tremor. ADCY5-related dyskinesia presents as a childhood-onset combined movement disorder. Wilson disease must always be considered in patients under 50 with dystonia because it is treatable.

<image>Table of major genetic dystonia syndromes showing gene, inheritance pattern, typical age of onset, body distribution, and distinguishing features</image>

## Acquired Dystonias

Drug-induced dystonia includes acute dystonic reactions from dopamine receptor blockers (treated with anticholinergics given IV or IM) and tardive dystonia from chronic neuroleptic use. Post-stroke or structural dystonia presents as hemidystonia contralateral to basal ganglia or thalamic lesions, often with delayed onset. Perinatal injury can produce cerebral palsy with a dystonic component. Autoimmune causes include anti-basal ganglia antibodies and post-infectious conditions in the Sydenham chorea spectrum. Wilson disease produces dystonia, parkinsonism, and psychiatric symptoms alongside liver disease, with Kayser-Fleischer rings and low ceruloplasmin levels.

## Treatment

### Botulinum Toxin Injections

Botulinum toxin is the first-line treatment for focal and segmental dystonias. Available formulations include onabotulinumtoxinA (Botox), abobotulinumtoxinA (Dysport), incobotulinumtoxinA (Xeomin), and rimabotulinumtoxinB (Myobloc). The mechanism involves blocking presynaptic acetylcholine release at the neuromuscular junction. For cervical dystonia, injections target the sternocleidomastoid, splenius capitis, trapezius, and levator scapulae depending on the pattern of abnormal posture. For blepharospasm, the orbicularis oculi is injected while avoiding the levator palpebrae. EMG or ultrasound guidance improves targeting of deep muscles. Effects last approximately 3 months, requiring repeat injections every 12-16 weeks. Antibody-mediated resistance can develop, particularly with higher doses and shorter intervals; switching to a different serotype or formulation may be necessary.

### Oral Medications

Anticholinergics, particularly trihexyphenidyl, are the most effective oral agents especially in children and young adults, titrated slowly to 6-30 mg/day. Their use is limited by cognitive and peripheral side effects in the elderly. Baclofen is particularly useful in children, and intrathecal baclofen may benefit lower limb and truncal dystonia. Benzodiazepines (clonazepam) serve an adjunctive role but carry risks of sedation and dependence. Levodopa serves as both a diagnostic and therapeutic trial that is mandatory in all childhood-onset dystonia to identify dopa-responsive dystonia. Tetrabenazine may help in tardive dystonia.

### Deep Brain Stimulation

GPi (globus pallidus internus) is the primary DBS target for dystonia. The best outcomes are achieved in DYT-TOR1A generalized dystonia, with 60-90% improvement at 1-3 years. Unlike PD DBS where benefit is immediate, improvement in dystonia is often gradual over months. GPi DBS is also effective in myoclonus-dystonia (DYT-SGCE), cervical dystonia refractory to botulinum toxin, and tardive dystonia. It is less effective in acquired dystonia from structural brain lesions. STN DBS has also been studied for dystonia with promising results.

### Selective Peripheral Denervation

This historical surgical approach for cervical dystonia involving selective denervation of involved muscles has been largely replaced by botulinum toxin and DBS. It may still have a role in botulinum toxin-resistant cases.

<image>Injection sites for botulinum toxin in cervical dystonia showing the key muscles targeted based on the pattern of abnormal head posture</image>

## Clinical Pearls

Any child presenting with dystonia deserves a levodopa trial regardless of other findings; missing dopa-responsive dystonia is a neurological tragedy because it is completely treatable with low-dose levodopa. Always screen for Wilson disease in patients under 50 with dystonia by obtaining serum ceruloplasmin, 24-hour urine copper, and slit-lamp examination. Hemidystonia in a child or young adult should prompt urgent MRI to evaluate for a structural basal ganglia lesion. The geste antagoniste (sensory trick) is highly specific for dystonia and helps differentiate it from other movement disorders. Fixed postures in dystonia may develop over time and become resistant to treatment, making early intervention important. Botulinum toxin injection for cervical dystonia should be based on the specific pattern of muscle activation using a validated classification such as the Col-Cap system, rather than a one-size-fits-all approach. Genetic testing should be considered in all early-onset generalized dystonia and in focal dystonia with family history.

## References
- Albanese A, Bhatia K, Bressman SB, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord. 2013;28(7):863-873.
- Volkmann J, Mueller J, Deuschl G, et al. Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial. Lancet Neurol. 2014;13(9):875-884.
- Vidailhet M, Vercueil L, Houeto JL, et al. Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia. N Engl J Med. 2005;352(5):459-467.
- Balint B, Mencacci NE, Valente EM, et al. Dystonia. Nat Rev Dis Primers. 2018;4(1):25.
- Simpson DM, Hallett M, Ashman EJ, et al. Practice guideline update: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache. Neurology. 2016;86(19):1818-1826.